Lord, Abbett & Co
VTYX

Lord, Abbett & Co’s Ventyx Biosciences VTYX Stock Holding History

Lord, Abbett & Co’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,729,464
Closed -$60.1M – 592
2023
Q3 		$60.1M Sell
1,729,464
-587,711
-25% -$20.3M 0.22% 128
2023
Q2 		$76M Buy
2,317,175
+998,782
+76% +$34.4M 0.26% 116
2023
Q1 		$44.2M Sell
1,318,393
-525,014
-28% -$20.4M 0.16% 204
2022
Q4 		$60.4M Buy
1,843,407
+105,629
+6% +$3.13M 0.22% 125
2022
Q3 		$60.7M Buy
+1,737,778
New +$38.5M 0.22% 124

Other funds holding VTYX

Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return